Compugen Stock Technical Analysis
| CGEN Stock | USD 2.14 0.03 1.42% |
As of the 22nd of January, Compugen shows the Risk Adjusted Performance of 0.0575, downside deviation of 3.53, and Mean Deviation of 3.05. Compugen technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Compugen Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Compugen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CompugenCompugen's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Compugen Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 5.8 | Strong Buy | 4 | Odds |
Most Compugen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Compugen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Compugen, talking to its executives and customers, or listening to Compugen conference calls.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets | Return On Equity |
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Compugen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Compugen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Compugen.
| 10/24/2025 |
| 01/22/2026 |
If you would invest 0.00 in Compugen on October 24, 2025 and sell it all today you would earn a total of 0.00 from holding Compugen or generate 0.0% return on investment in Compugen over 90 days. Compugen is related to or competes with Innate Pharma, Nuvectis Pharma, Molecular Partners, Milestone Pharmaceuticals, Rani Therapeutics, Tonix Pharmaceuticals, and Cardiff Oncology. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes ... More
Compugen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Compugen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Compugen upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.53 | |||
| Information Ratio | 0.0421 | |||
| Maximum Drawdown | 22.26 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 7.78 |
Compugen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Compugen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Compugen's standard deviation. In reality, there are many statistical measures that can use Compugen historical prices to predict the future Compugen's volatility.| Risk Adjusted Performance | 0.0575 | |||
| Jensen Alpha | 0.1991 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.0505 | |||
| Treynor Ratio | 0.3497 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Compugen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Compugen January 22, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0575 | |||
| Market Risk Adjusted Performance | 0.3597 | |||
| Mean Deviation | 3.05 | |||
| Semi Deviation | 3.09 | |||
| Downside Deviation | 3.53 | |||
| Coefficient Of Variation | 1500.62 | |||
| Standard Deviation | 4.24 | |||
| Variance | 17.96 | |||
| Information Ratio | 0.0421 | |||
| Jensen Alpha | 0.1991 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.0505 | |||
| Treynor Ratio | 0.3497 | |||
| Maximum Drawdown | 22.26 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 7.78 | |||
| Downside Variance | 12.47 | |||
| Semi Variance | 9.55 | |||
| Expected Short fall | (4.01) | |||
| Skewness | 1.06 | |||
| Kurtosis | 1.9 |
Compugen Backtested Returns
Compugen appears to be very risky, given 3 months investment horizon. Compugen secures Sharpe Ratio (or Efficiency) of 0.0876, which signifies that the company had a 0.0876 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Compugen, which you can use to evaluate the volatility of the firm. Please makes use of Compugen's Mean Deviation of 3.05, risk adjusted performance of 0.0575, and Downside Deviation of 3.53 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Compugen holds a performance score of 6. The firm shows a Beta (market volatility) of 0.78, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Compugen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Compugen is expected to be smaller as well. Please check Compugen's total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether Compugen's price patterns will revert.
Auto-correlation | -0.59 |
Good reverse predictability
Compugen has good reverse predictability. Overlapping area represents the amount of predictability between Compugen time series from 24th of October 2025 to 8th of December 2025 and 8th of December 2025 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Compugen price movement. The serial correlation of -0.59 indicates that roughly 59.0% of current Compugen price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.59 | |
| Spearman Rank Test | -0.51 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Compugen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Compugen Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Compugen volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Compugen Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Compugen on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Compugen based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Compugen price pattern first instead of the macroeconomic environment surrounding Compugen. By analyzing Compugen's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Compugen's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Compugen specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2025 | 2026 (projected) | PB Ratio | 2.67 | 2.24 | 3.62 | Capex To Depreciation | 0.36 | 0.22 | 0.21 |
Compugen January 22, 2026 Technical Indicators
Most technical analysis of Compugen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Compugen from various momentum indicators to cycle indicators. When you analyze Compugen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0575 | |||
| Market Risk Adjusted Performance | 0.3597 | |||
| Mean Deviation | 3.05 | |||
| Semi Deviation | 3.09 | |||
| Downside Deviation | 3.53 | |||
| Coefficient Of Variation | 1500.62 | |||
| Standard Deviation | 4.24 | |||
| Variance | 17.96 | |||
| Information Ratio | 0.0421 | |||
| Jensen Alpha | 0.1991 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.0505 | |||
| Treynor Ratio | 0.3497 | |||
| Maximum Drawdown | 22.26 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 7.78 | |||
| Downside Variance | 12.47 | |||
| Semi Variance | 9.55 | |||
| Expected Short fall | (4.01) | |||
| Skewness | 1.06 | |||
| Kurtosis | 1.9 |
Compugen January 22, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Compugen stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 8,649 | ||
| Daily Balance Of Power | 0.33 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 2.17 | ||
| Day Typical Price | 2.16 | ||
| Price Action Indicator | (0.01) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets | Return On Equity |
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.